Dr. Anne M. Larson Named Director of The Liver Center at Swedish

2011
August
19

The Fearey Group

SEATTLE, Wash. – August 19, 2011 – As part of our continuing effort to expand access to care for patients with liver disease, Swedish has named Anne M. Larson, M.D., director of The Liver Center at Swedish Medical Center. 

In her new role, Dr. Larson will oversee The Liver Center, a program that promotes customized treat­ment plans that include liver disease management, medical and surgical options, the use of state-of-the-art technologies, and liver transplantation.

Dr. Larson comes to Swedish from the Uni­versity of Texas South­western in Dallas, Texas, where she was the medical director of the Liver Transplantation Program and Clinical Hepatology.  She received her medical degree with honors and completed her internal medicine residency at the University of Washington School of Medicine in Seattle.  She did her gastroenterology fellow­ship training at the University of California San Diego, and her transplant hepatology fellowship at the University of Washington. She is board certified in internal medicine, gastroenterology and transplant hepatology. Dr. Larson is a nationally recognized research­er and lecturer, has numerous peer-reviewed publications, and is recognized as a leader in the field of hepatology.

“We are thrilled to be joined by Dr. Larson,” said Marquis Hart, M.D., director of the Swedish Transplant Program, “and we look forward to her clinical expertise, guidance and leadership at the Swedish Liver Center.”

The Liver Center at Swedish of­fers a comprehensive approach to managing liver disease. Given the expertise of its team members and broad scope of treatments and services, Swedish is able to personalize each patient’s treat­ment. The Liver Center offers the most advanced technologies and newest strategies in the treatment of disease to extend life and enhance quality of life, from hepatitis to end-stage liver disease to liver cancer.

“I am excited and honored to be a part of The Swedish Liver Center,” said Dr. Larson. “We look forward to providing a full range of services to the patient with liver disease.”

The appointment of Dr. Larson is another example of Swedish’s commitment to the Pacific Northwest community and patients to provide the highest possible level of treatments to those with liver disease. 

About the Liver Center at Swedish

The Liver Center at Swedish of­fers a comprehensive approach to managing liver disease. Given the expertise of its team members and broad scope of treatments and services, Swedish is able to personalize each patient’s treat­ment. The Liver Center offers the most advanced technologies and newest strategies in the treatment of disease, from hepatitis to end-stage liver disease to liver cancer, to extend life and enhance quality of life.

About Swedish

Swedish has grown over the last 100 years to become the largest, most comprehensive non-profit health provider in the Greater Seattle area with 8,500 employees, 3,000-physicians and 1,200-volunteers. It is comprised of four hospital campuses (First Hill, Cherry Hill, Ballard and Edmonds); emergency departments and ambulatory care centers in Issaquah, Redmond and Mill Creek; Swedish Visiting Nurse Services; and Swedish Medical Group – a network of more than 70 primary-care and specialty clinics located throughout the Greater Puget Sound area. Swedish recently opened a new emergency department and medical office building (MOB) on its Ballard campus as well as its Issaquah campus. It will open a new hospital in the Issaquah Highlands in November. In addition to general medical and surgical care, Swedish is known as a regional referral center, providing specialized treatment in areas such as cardiovascular care, cancer care, neuroscience, orthopedics, high-risk obstetrics, pediatric specialties, organ transplantation and clinical research. For more information, visit Swedish online at www.swedish.org, www.swedishcares.orgwww.facebook.com/swedishmedicalcenter or www.twitter.com/swedish.

In 2007, Swedish embarked upon an ambitious $100 million fundraising campaign. Campaign investments are used to support a wide-variety of initiatives throughout the health-care system, including cancer, heart and vascular, women and children, neurosciences, and orthopedics as well as programs to support underserved populations. To date, the campaign has secured gifts totaling more than $74 million. For more information or to support the campaign, visit www.campaignforswedish.org

# # #